Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model
Open Access
- 23 August 2010
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 60 (2) , 142-146
Abstract
Efforts are underway for the development of an effective vaccine against Helicobacter pylori infection. We prepared recombinant full-length (568 aa)Keywords
This publication has 27 references indexed in Scilit:
- Antibody-Mediated Protection against Infection withHelicobacter pyloriin a Suckling Mouse Model of Passive ImmunityInfection and Immunity, 2009
- Immunogenicity of Recombinant Helicobacter pylori Urease B Administered by Various Routes and with Different AdjuvantsThe Open Vaccine Journal, 2009
- Protection Against Helicobacter pylori Infection in Mongolian Gerbil by Intragastric or Intramuscular Administration of H. pylori Multicomponent VaccineHelicobacter, 2008
- Real-time PCR for Quantification of Helicobacter felis in Mouse StomachSouthern Medical Journal, 2006
- Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-AVaccine, 2006
- Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical InfectionInfection and Immunity, 2001
- Parenteral Adjuvant Activities ofEscherichia coliHeat-Labile Toxin and Its B Subunit for Immunization of Mice against GastricHelicobacter pyloriInfectionInfection and Immunity, 2000
- Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infectionThe Lancet, 1996
- Development of a PCR-based technique for detection ofHelicobacter pyloriFEMS Immunology & Medical Microbiology, 1995
- Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunizationVaccine, 1993